Use of Zebrafish to Identify New CNS Drugs Acting Through Nicotinic and Dopaminergic Systems
Book:
Frontiers in CNS Drug Discovery
Page:
381-406
Author(s):
Robert T. Boyd
Application of Monoterpenoids and their Derivatives Against CNS Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
334-380
Author(s):
Alla V. Pavlova, Konstantin P. Volcho and Tatyana G. Tolstikova
Essential Polyunsaturated Fatty Acids as New Treatments for Neurodegenerative Diseases
Book:
Frontiers in CNS Drug Discovery
Page:
312-333
Author(s):
Cai Song
Flavonoids – Their Preventer and Therapeutic Applications Against Parkinson’s Disease
Book:
Frontiers in CNS Drug Discovery
Page:
281-311
Author(s):
Elena González-Burgos and Maria P. Gómez-Serranillos
The Role of Natural Products on the Discovery of New Drug Candidates for Neurogenerative Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
211-280
Author(s):
Flávia P.D. Viegas, Rodolfo do C. Maia, Roberta Tesch, Carlos A.M. Fraga and Claudio Viegas
Antipsychotic Polypharmacy in Schizophrenia, from Empirical Associations to Combined Selective Treatments
Book:
Frontiers in CNS Drug Discovery
Page:
146-210
Author(s):
Alessandro De Risio and Davide Carlino
Transient Receptor Potential Ion Channels as Promising Therapeutic Targets: An Overview
Book:
Frontiers in CNS Drug Discovery
Page:
118-145
Author(s):
Merab G. Tsagareli
New Therapies for HIV-1-Associated Neurocognitive Disorder (HAND): Animal Models and Gene Delivery of Antioxidant Enzymes by rSV40
Book:
Frontiers in CNS Drug Discovery
Page:
80-117
Author(s):
Jean-Pierre Louboutin and David S. Strayer
Manipulation of Endogenous Neural Stem Cells as a Therapeutic Strategy for Neurodegenerative Diseases: Insights from Animal Models
Book:
Frontiers in CNS Drug Discovery
Page:
43-79
Author(s):
Anna Patten, Patricia S. Brocardo and Joana M. Gil-Mohapel
Epigenetic Modifications as Novel Targets for Drug Addiction
Book:
Frontiers in CNS Drug Discovery
Page:
26-42
Author(s):
Candace R. Lewis and Michael F. Olive